Wutah pendapatan taun lumaku: Fortrea Holdings Inc. (FTRE)

Logo grafis Fortrea Clinical (FTRE)

Fortrea Holdings Inc. generates revenue through global support for all stages of biomedical development. The TTM sales volume change metric visualizes the actual cash inflow, where the value -3.50 determines this level. Stability is ensured by the resilience of R&D budgets to crises, while maximum laboratory utilization coupled with the implementation of automation eliminates any capacity downtime.

FTRE - Wutah pendapatan YoY sajrone 12 wulan kepungkur fortrea.com ing rentang 23.11.2025 - 18.11.2026

Fortrea Clinical (FTRE) - rincian metrik lan laporan keuangan

- rega saham lan konsensus proyeksi valuasi:
- indikator kapitalisasi bursa perusahaan:
Ringkesan analitik perusahaan:FTRE (Fortrea Holdings Inc.)
Produk merek Fortrea Corp

Fortrea Holdings Inc. provides critical temperature-controlled biosample logistics, making its revenue dependent on global clinical trial volumes. Analyzing the 12-month annual revenue trajectory allows for the filtering of market noise, measuring the real pace of business expansion and confirming sustained demand for the company's services by comparing current rolling periods with the previous year.